Pinnacle Associates’s Ocugen OCGN Stock Holding History

Pinnacle Associates’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$2K	–	693
2020 Q2	$2K	Buy	+10,000	New	+$3.01K	﹤0.01%	675

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SIA

Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pinnacle Associates's OCGN Position: Q3 2020 in Review

Pinnacle Associates sold out of Ocugen (OCGN) in Q3 2020, closing a stake of 10,000 shares — an estimated $2K sold.

Pinnacle Associates first reported a position in OCGN in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 19 funds tracked by Wall St. Rank hold OCGN as of Q3 2020.

Pinnacle Associates reported no remaining Ocugen position as of Q3 2020 after selling out during the quarter.
Pinnacle Associates sold 10,000 Ocugen shares in Q3 2020, an estimated $2K.
Pinnacle Associates first reported a position in Ocugen in Q2 2020 and held it in 1 quarter.
Pinnacle Associates's Ocugen position peaked at $2K in Q2 2020.
19 funds tracked by Wall St. Rank held Ocugen as of Q3 2020.

Based on Pinnacle Associates's 13F filing for Q3 2020, filed 23 Oct 2020.